Vivid Dx
Vivid Dx is a diagnostics company that has developed a next-generation platform for rapid detection of sepsis-causing pathogens and antimicrobial resistance (AMR). Their technology utilizes single-cell Raman spectroscopy combined with advanced AI and machine learning to provide broad pathogen identification in 30 minutes and phenotypic AST results in 3 hours, directly from blood. This approach bypasses the need for traditional blood cultures, which take 2-3 days, thereby enabling faster clinical decisions, improving patient outcomes, and reducing healthcare costs. The company was born at Oxford and is backed by science, aiming to disrupt the multibillion-dollar blood culture-based diagnostics market.
Vivid Dx
Vivid Dx is a diagnostics company that has developed a next-generation platform for rapid detection of sepsis-causing pathogens and antimicrobial resistance (AMR). Their technology utilizes single-cell Raman spectroscopy combined with advanced AI and machine learning to provide broad pathogen identification in 30 minutes and phenotypic AST results in 3 hours, directly from blood. This approach bypasses the need for traditional blood cultures, which take 2-3 days, thereby enabling faster clinical decisions, improving patient outcomes, and reducing healthcare costs. The company was born at Oxford and is backed by science, aiming to disrupt the multibillion-dollar blood culture-based diagnostics market.